Game on: new study uses video game to boost HPV shots in teens
NCT ID NCT05984849
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether a health-themed video game can encourage HPV vaccination among underserved youth aged 11-14 who have not yet received the vaccine. About 180 parent-child pairs will play the game and report their vaccination intentions and actual shots. The goal is to see if this fun approach is feasible and can increase vaccine uptake to prevent HPV-related cancers.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- health game to promote HPV vaccination
- What this could lead to
- If it works, this could provide a fun, effective way to increase HPV vaccination rates in vulnerable youth, potentially preventing many cancers.
- What could go wrong
- This is a small pilot study (180 participants) testing feasibility, not effectiveness. The game may not actually increase vaccination rates, and results may not apply to other groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 180 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
11 to 14 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Child sample: (1) 11-14 years old, (2) speaks and reads English, (3) has never received any doses of the HPV vaccine, (4) is not currently enrolled in another project that involves HPV-related education, and (5) agrees and provides assent to participate in research activities. * Parent sample: (1) parent or legal guardian of the participating child, (2) speak and read English, (3) own a smartphone, (4) agree to receive email and text messages, (5) is not currently enrolled in another project that involves HPV-related education, and (6) agree and provide consent to participate in research activities. Exclusion Criteria: Individuals who do not meet inclusion criteria or refuse to provide consent/assent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Community
RECRUITINGChandler, Arizona, 85224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an HPV shot stop vulvar lesions from coming back?
- MRI scans may reveal which throat cancer patients need stronger treatment
- Could a single HPV shot match the standard regimen?
- Can a vaccine shield transplant patients from shingles?
- Could Self-Sampling revolutionize cervical cancer screening?
- Texting parents could be key to curbing HPV-Related cancers